GlassScriptPhysician profile
Alexandre P Ancheta
NPI 1316237951
$2,529.47
in general payments reported to CMS, 2019-2025
8 companies · $95.52 in 2025
The $95.52 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.25 · 2020: $22.22 · 2021: $172 · 2023: $15.16 · 2024: $2,164 · 2025: $95.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,833 · Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,832.70 |
| Food and Beverage | $441.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $1,832.70 | 2024 | Organ Care System |
| Medtronic, INC. | $330.81 | 2024 | Signia |
| Boston Scientific Corporation | $156.89 | 2021 | |
| Merck Sharp & Dohme LLC | $95.52 | 2025 | Prevymis |
| Janssen Pharmaceuticals, INC | $44.02 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.45 | 2019-2020 | |
| Baxter Healthcare | $15.16 | 2023 | Hillrom - Life 2000 Ventilation System |
| Qol Medical, LLC | $14.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandre Ancheta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.